OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Pulmonary Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	48
The persistent problem of persistent air-leaks: approach to management	40
Bronchoscopic treatment of early-stage peripheral lung cancer	35
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	34
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	34
Digital outcome measures in pulmonary clinical trials	29
Home monitoring in asthma: towards digital twins	29
Improving care in lung cancer surgery: a review of quality measures and evolving standards	27
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	26
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	25
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	23
Group 2 pulmonary hypertension: from diagnosis to treatment	23
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	22
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	22
Implementation of digital home monitoring and management of respiratory disease	20
Editorial introductions	19
Lung transplant referral considerations for individuals with cystic fibrosis	19
Asthma in pregnancy: a review of recent literature	18
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	17
Cystic fibrosis liver disease in the post-modulator era	16
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	16
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	16
The future of clinical trials in idiopathic pulmonary fibrosis	16
Casting light on the many facets of sarcoidosis	16
Considerations and clinical management of infections in sarcoidosis	16

An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	15
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	15
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	15
Progress for all: addressing disparities in sarcoidosis	14
Digital inhalers for asthma management	14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	14
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	14
Tobacco treatment in the setting of lung cancer screening	14
Home monitoring of coronavirus disease 2019 patients in different phases of disease	14
Acute rejection post lung transplant	13
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	13
What causes cough in pulmonary fibrosis, and how should we treat it?	13
Imaging in peripheral bronchoscopy	13
Exhaled breath analysis in interstitial lung disease	12
Editorial: Are we ready for prime time?	12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	12
Effectiveness and safety of coronavirus disease 2019 vaccines	12
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	11
Telerehabilitation in pulmonary diseases	11
Patterns of progression in non-IPF fibrotic interstitial lung disease	11
Multidisciplinary care in nonmalignant central airway obstruction	11
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	11
Infection control in cystic fibrosis: evolving perspectives and challenges	11
The association of preexisting severe asthma with COVID-19 outcomes	10
Epigenetics and aging: relevance for sleep medicine	10
Editorial: ‘What is your occupation?’: historical snippets	10
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	10
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	10
Adenotonsillectomy: the good, the bad and the unknown	10
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	10
The changing landscape of infections in the lung transplant recipient	10
Ergonomics in bronchoscopy	9
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	9
Long-term safety, durability of response, cessation and switching of biologics	9
Right ventricular assessment in pulmonary hypertension	9
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	9
Military deployment-related respiratory problems: an update	9
Advancements in airway stents: a comprehensive update	9
Prader–Willi syndrome: an update	9
Approach to the hospitalized patient with pulmonary arterial hypertension	9
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	8
Editorial introductions	8
Health inequities in the modulator era	8
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	8
Bronchoscopic lung volume reduction in emphysema: a review	8
Editorial introductions	8
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	8
Pulmonary alveolar proteinosis – current and future therapeutical strategies	8

Recent advances predict a bright future for nebulizers	8
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	8
Updates in the diagnosis and management of chronic thromboembolic disease	8
Artificial intelligence for the optimal management of community-acquired pneumonia	8
Editorial introductions	8
Bacteriophages for bronchiectasis: treatment of the future?	7
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	7
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	7
Bronchoscopic interventions for chronic bronchitis	7
Editorial introductions	7
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	7
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	6
Editorial introductions	6
Indwelling pleural catheters for benign pleural effusions: a concise review	6
Recent developments in occupational asthma	6
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	6
Interstitial lung disease following coronavirus disease 2019	6
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	6
What is new in mediastinal staging?	6
Lung infections due to emerging fungal pathogens	6
Anesthetic considerations in interventional pulmonology	5
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	5
Editorial introductions	5
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	5
Risk stratification of pulmonary embolism	5
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	5
Management of complicated parapneumonic effusions	5
Whole lung lavage: considerations from the anesthesiology perspective	5
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	5
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	5
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	5
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	5
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	5
Bedside to bench and back again-translational research in interventional pulmonology	4
Vitamin D deficiency in chronic obstructive pulmonary disease	4
Sex differences in sleep and sleep-disordered breathing	4
Diversity and disparity in the treatment and care of sarcoidosis	4
Leveraging AI technology in sarcoidosis	4
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis	4
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	4
Glymphatic MRI techniques in sleep and neurodegenerative diseases	4
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	4
Progress and challenges in fungal lung disease in cystic fibrosis	4
Pregnancy and fertility in people with cystic fibrosis following lung transplantation	4
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	4
The controversy over daylight saving time: evidence for and against	4
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	4
Lung transplantation: practical and important directions of care	4
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	4
Update on the genetic basis of obstructive sleep apnoea – hype or hope?	4